DK2268299T3 - Sammensætninger til reduktion af ardannelse under sårheling - Google Patents

Sammensætninger til reduktion af ardannelse under sårheling

Info

Publication number: DK2268299T3
Authority: DK; Denmark
Prior art keywords: compositions; wound healing; during wound; reducing scarring; scarring during
Prior art date: 2008-04-01

Application number

DK09728723.9T

Other languages

English (en)

Inventor

Peter Jozef Jacobus Moonen

Christiaan Peter Maria Reutelingsperger

Ad Vermaire

Original Assignee

Mosamedix Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-01

Filing date

2009-04-01

Publication date

2013-10-07

2009-04-01 Application filed by Mosamedix Bv filed Critical Mosamedix Bv

2013-10-07 Application granted granted Critical

2013-10-07 Publication of DK2268299T3 publication Critical patent/DK2268299T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Dermatology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dispersion Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Marine Sciences & Fisheries (AREA)
Zoology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

DK09728723.9T 2008-04-01 2009-04-01 Sammensætninger til reduktion af ardannelse under sårheling DK2268299T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4127808P	2008-04-01	2008-04-01
PCT/NL2009/050169 WO2009123454A1 (en)	2008-04-01	2009-04-01	Compositions and method for reducing scar formation in wound healing

Publications (1)

Publication Number	Publication Date
DK2268299T3 true DK2268299T3 (da)	2013-10-07

Family

ID=40996620

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK09728723.9T DK2268299T3 (da)	2008-04-01	2009-04-01	Sammensætninger til reduktion af ardannelse under sårheling

Country Status (8)

Country	Link
US (1)	US8377881B2 (da)
EP (1)	EP2268299B1 (da)
JP (1)	JP5792057B2 (da)
AU (1)	AU2009232478B2 (da)
CA (1)	CA2720280C (da)
DK (1)	DK2268299T3 (da)
ES (1)	ES2429122T3 (da)
WO (1)	WO2009123454A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
PT2359808E (pt)	2006-08-09	2013-08-28	Intarcia Therapeutics Inc	Sistemas de entrega osmótica e montagens de pistão
PL2157967T3 (pl)	2007-04-23	2013-06-28	Intarcia Therapeutics Inc	Formulacje zawiesinowe peptydów insulinotropowych i ich zastosowania
CA2726861C (en)	2008-02-13	2014-05-27	Intarcia Therapeutics, Inc.	Devices, formulations, and methods for delivery of multiple beneficial agents
US20100178259A1 (en) *	2009-01-12	2010-07-15	The Regents Of The University Of Michigan	Reducing fibrosis using matrix metalloproteinase inhibitors
HUE035862T2 (en)	2009-09-28	2018-05-28	Intarcia Therapeutics Inc	Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
MX2017015504A (es) *	2015-06-03	2018-05-15	Intarcia Therapeutics Inc	Sistemas de colocacion y remoción de implante.
CA3024479A1 (en)	2016-05-16	2017-11-23	Intarcia Therapeutics, Inc.	Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
CN110225762A (zh)	2017-01-03	2019-09-10	因塔西亚制药公司	包括glp-1受体激动剂的连续施用和药物的共同施用的方法
USD933219S1 (en)	2018-07-13	2021-10-12	Intarcia Therapeutics, Inc.	Implant removal tool and assembly
CN118001374A (zh) *	2023-02-13	2024-05-10	上海萨美细胞技术有限公司	一种抗皮肤纤维化的药物
CN118001375A (zh) *	2023-04-12	2024-05-10	上海萨美细胞技术有限公司	一种用于难愈性创面修复的药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5360789A (en)	1990-11-20	1994-11-01	Kowa Co., Ltd.	Therapeutic agent for skin or corneal disease
US6333347B1 (en)	1999-01-29	2001-12-25	Angiotech Pharmaceuticals & Advanced Research Tech	Intrapericardial delivery of anti-microtubule agents
US7511016B2 (en) *	2004-07-07	2009-03-31	Mosamedix B.V.	Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof
CA2633033C (en)	2005-12-12	2016-11-22	Mosamedix B.V.	Annexin derivatives suitable for pretargeting in therapy and diagnosis

2009
- 2009-04-01 WO PCT/NL2009/050169 patent/WO2009123454A1/en active Application Filing
- 2009-04-01 JP JP2011502881A patent/JP5792057B2/ja not_active Expired - Fee Related
- 2009-04-01 EP EP09728723.9A patent/EP2268299B1/en not_active Not-in-force
- 2009-04-01 DK DK09728723.9T patent/DK2268299T3/da active
- 2009-04-01 CA CA2720280A patent/CA2720280C/en active Active
- 2009-04-01 ES ES09728723T patent/ES2429122T3/es active Active
- 2009-04-01 US US12/935,900 patent/US8377881B2/en not_active Expired - Fee Related
- 2009-04-01 AU AU2009232478A patent/AU2009232478B2/en not_active Ceased

Also Published As

Publication number	Publication date
EP2268299A1 (en)	2011-01-05
JP2011516469A (ja)	2011-05-26
EP2268299B1 (en)	2013-07-17
WO2009123454A1 (en)	2009-10-08
AU2009232478B2 (en)	2014-11-06
CA2720280C (en)	2018-02-20
US20110091527A1 (en)	2011-04-21
ES2429122T3 (es)	2013-11-13
AU2009232478A1 (en)	2009-10-08
CA2720280A1 (en)	2009-10-08
JP5792057B2 (ja)	2015-10-07
US8377881B2 (en)	2013-02-19

Publication	Publication Date	Title
DK2268299T3 (da)	2013-10-07	Sammensætninger til reduktion af ardannelse under sårheling
CY2020023I1 (el)	2020-11-25	Αναστολεiς βητα-λακταμασων
LTPA2019009I1 (lt)	2019-04-10	C7-fluoru pakeisti tetraciklino junginiai
DK2498829T3 (da)	2014-08-11	Komponent til sårforbinding
DK2379033T3 (da)	2013-12-16	Sårplaster
EP2262474A4 (en)	2013-03-27	METHOD AND COMPOSITIONS FOR WOUND HEALING
DK2634232T3 (da)	2022-06-07	Sammensætninger
BRPI0906749A2 (pt)	2015-07-07	Composição
BRPI0913808A2 (pt)	2017-06-20	composição
BRPI0915593A2 (pt)	2016-02-02	Curativo de ferida
EP2346459A4 (en)	2013-03-27	BENDING WUNDAUFLAGE
DE602008002756D1 (de)	2010-11-04	Bauzusammensetzung
FR2941462B1 (fr)	2013-07-05	Composition decapante
BRPI0912281A2 (pt)	2015-10-20	curativo de feridas
BRPI0917231A2 (pt)	2015-11-10	composição
DK2310034T3 (da)	2014-04-28	Peptider til behandling af beta-amyloidose
BRPI0918602A2 (pt)	2015-12-15	composto (i)
IT1392101B1 (it)	2012-02-09	Composizione comprendente isoflavoni
BRPI0918564A2 (pt)	2015-12-01	inibidores
EP2283967A4 (en)	2011-09-28	INDEXABLE TABLE
EP2496264A4 (en)	2014-03-26	Composition for promoting wound healing
EP2280032A4 (en)	2014-04-02	PHOTOPOLYMERIZABLE COMPOSITIONS
BRPI0910691A2 (pt)	2018-03-27	compostos e composições como inibidores de itpkb
EP2357204A4 (en)	2012-06-27	COMPOSITION
BRPI0923253A2 (pt)	2016-01-26	composições depilatória